FSMDX
Price
$42.59
Change
+$0.08 (+0.19%)
Updated
Jul 2 closing price
Net Assets
53.23B
GMXRX
Price
$16.69
Change
-$0.07 (-0.42%)
Updated
Jul 2 closing price
Net Assets
486.81M
Interact to see
Advertisement

FSMDX vs GMXRX

FSMDX vs GMXRX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. GMXRX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Hold and GMXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 53.2B vs. GMXRX (487M). FSMDX pays higher dividends than GMXRX: FSMDX (0.76) vs GMXRX (0.39). FSMDX was incepted earlier than GMXRX: FSMDX (15 years) vs GMXRX (19 years). GMXRX (1.03) is less costly to investors than FSMDX (0.03). GMXRX (15.69) and FSMDX (15.00) have comparable annual turnover. FSMDX (0) and GMXRX (0) have matching initial minimum investment requirements. FSMDX annual gain was more profitable for investors over the last year : 20.14 vs. GMXRX (7.06). FSMDX return over 5 years is better than : 43.77 vs. GMXRX (-10.79).
FSMDXGMXRXFSMDX / GMXRX
Total Expense Ratio0.031.003%
Annual Report Gross Expense Ratio0.031.032%
Fund Existence15 years19 years-
Gain YTD15.32615.295100%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets53.2B487M10,924%
Annual Yield % from dividends0.760.39193%
Returns for 1 year20.147.06285%
Returns for 3 years55.8710.87514%
Returns for 5 years43.77-10.79-406%
Returns for 10 years174.444.993,495%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHAT11.200.66
+6.31%
Phathom Pharmaceuticals
IQV207.043.84
+1.89%
IQVIA Holdings
MKTX116.532.04
+1.78%
MarketAxess Holdings
NVNI0.99N/A
N/A
Nvni Group Limited
HTLM1.87-0.10
-5.08%
HomesToLife Ltd